Contact

• workRoom A01b Applied Health Sciences Building
  University Park
  Nottingham
  NG7 2RD
  UK
• Rebecca.Haydock@nottingham.ac.uk

Biography

Rebecca began her clinical trial career in 2012, working for a Phase 1 clinical research organisation. In 2015 she began working at the Nottingham Clinical Trials Unit where she now works as a Senior Trial Manager. Rebecca supports the trial management of the BEEP, DEVA, FAMOUS and GBS3 trials.

Research Summary

A randomised controlled trial to determine whether application of emollient from birth can prevent eczema in high risk children:… read more

Recent Publications

• MCKEEVER T, MORTIMER K, WILSON A, WALKER S, BRIGHTLING C, SKEGGS A, PAVORD I, PRICE D, DULEY L, THOMAS M, BRADSHAW L, HIGGINS B, HAYDOCK R, MITCHELL E, DEVEREUX G and HARRISON T, 2018. Quadrupling Inhaled Glucocorticoid Dose to Abort Asthma Exacerbations. The New England journal of medicine. 378(10), 902-910
• SKEGGS A, MCKEEVER T, DULEY L, MITCHELL E, BRADSHAW L, MORTIMER K, WALKER S, PARROTT S, WILSON A, PAVORD I, BRIGHTLING C, THOMAS M, PRICE D, DEVEREUX G, HIGGINS B, HARRISON T and HAYDOCK R, 2016. FourFold Asthma Study (FAST): a study protocol for a randomised controlled trial evaluating the clinical cost-effectiveness of temporarily quadrupling the dose of inhaled steroid to prevent asthma exacerbations. Trials. 17(1), 499

• View all publications

Current Research

A randomised controlled trial to determine whether application of emollient from birth can prevent eczema in high risk children: https://www.nottingham.ac.uk/research/groups/cebd/projects/1eczema/beep-maintrial.aspx

A randomised controlled trial comparing dequalinium chloride with usual care antibiotics in patientd with symptoms of BV: https://www.devastudy.ac.uk/

A large cluster randomised trial investigation the follow-up and structured monitoring for adults offered an NHS hearing aid for the first time : www.famousstudy.ac.uk

A large randomised cluster trial investigating routine testing for Group B Streptococcus in Pregnancy: https://www.gbs3trial.ac.uk/home.aspx

Past Research

TANDEM TRIAL: a factorial randomised controlled trial of dose and review schedule of bevacizumab (Avastin) for neovascular macular degeneration in the East Midlands. BMJ Open Ophthalmology 2020;5:e000588. DOI: 10.1136/bmjophth-2020-000588

Quadrupling Inhaled Glucocorticoid Dose to Abort Asthma Exacerbations. N Engl J Med 2018; 378:902-910. DOI: 10.1056/NEJMoa1714257

• MCKEEVER T, MORTIMER K, WILSON A, WALKER S, BRIGHTLING C, SKEGGS A, PAVORD I, PRICE D, DULEY L, THOMAS M, BRADSHAW L, HIGGINS B, HAYDOCK R, MITCHELL E, DEVEREUX G and HARRISON T, 2018. Quadrupling Inhaled Glucocorticoid Dose to Abort Asthma Exacerbations. The New England journal of medicine. 378(10), 902-910
• SKEGGS A, MCKEEVER T, DULEY L, MITCHELL E, BRADSHAW L, MORTIMER K, WALKER S, PARROTT S, WILSON A, PAVORD I, BRIGHTLING C, THOMAS M, PRICE D, DEVEREUX G, HIGGINS B, HARRISON T and HAYDOCK R, 2016. FourFold Asthma Study (FAST): a study protocol for a randomised controlled trial evaluating the clinical cost-effectiveness of temporarily quadrupling the dose of inhaled steroid to prevent asthma exacerbations. Trials. 17(1), 499